Cargando…

Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report

This online workshop Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps was organized on October 14th, 2021, by the Animal Free Safety Assessment Collaboration (AFSA), the Humane Society International (HSI), the European Federation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Viviani, Laura, Reid, Kirsty, Gastineau, Thierry, Milne, Catherine, Smith, Dean, Levis, Robin, Lei, Dianliang, van Ooij, Mark, Gilbert, Philippe Alexandre, Vandeputte, Joris, Xie, Jianxun, Madhuri, Leena, Shaid, Shahjahan, Kubiak, Vaughn, Suri, Rajinder, Mizukami, Takuo, Shirasaki, Yoshihisa, Li, Xiantang, Zhou, Ying-Ying, Trapkova, Alla, Goel, Sunil, Prakash, Jai, Subagio, Amrullah Aninditio, Suwarni, Eniek, Jung, Kyung Jin, Sanyal, Gautam, Das, Pradip, Coppens, Emmanuelle, Wright, David, Peng, Zhechu, Northeved, Helle, Jungbäck, Carmen, Kirpitchenok, Tatiana, Del Pace, Lorenzo, Seo, Borami, Poojary, Brinda, Ottoni, Antoniana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490484/
https://www.ncbi.nlm.nih.gov/pubmed/35840492
http://dx.doi.org/10.1016/j.biologicals.2022.06.003
Descripción
Sumario:This online workshop Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps was organized on October 14th, 2021, by the Animal Free Safety Assessment Collaboration (AFSA), the Humane Society International (HSI), the European Federation of Pharmaceutical Industries and Associations (EFPIA), in collaboration with the International Alliance of Biological Standardization (IABS). The workshop saw a participation of over a hundred representatives from international organizations, pharmaceutical industries and associations, and regulatory authorities of 28 countries. Participants reported on country- and region-specific regulatory requirements and, where present, on the perspectives on the waiving and elimination of the Abnormal Toxicity Test. With AFSA, HSI, EFPIA and IABS representatives as facilitators, the participants also discussed specific country/global actions to further secure the deletion of ATT from all regulatory requirements worldwide.